The Globe and Mail reports in its Friday, Feb. 2, edition that Boralex is a "Top Pick" for Desjardins Securities analyst Brent Stadler. The Globe's David Leeder writes in the Eye On Equities column that Mr. Stadler has an unchanged share target of $44. Analysts on average target the shares at $40.10. Mr. Stadler says in a note: "Given its positioning in Canada, France (where it is the No. 1 IPP), the U.S. and its more recent success in the UK, we continue to believe Boralex's growth outlook is positive. In our view, Boralex is the onshore renewables name to own, given its retained FCF, ability to manage industry headwinds, and its delivery of projects largely on schedule and on budget, as well as its impressive rate of backfilling MW in its development pipeline." The Globe reported on July 21, Sept. 12 and Jan. 30 that Mr. Stadler rated Boralex "buy." The shares were then worth $35.32, $32.51 and $32.50. The Globe reported on Jan. 10 that CIBC World Markets analyst Mark Jarvi had reaffirmed his "outperformer" recommendation for Boralex. The shares could then be had for $33.72.